Wall St. bounces back, led by industrials
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Pfizer (PFE) Reports Marketing Authorization in European Union from Euro Commission for Moderately to Severely Active Ulcerative Colitis
August 1, 2018 6:30 AM EDTPfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has approved XELJANZ® (tofacitinib citrate) 10 mg twice-daily (BID) for at least eight weeks, followed by XELJANZ 5 mg BID or 10 mg BID, for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.1 XELJANZ is the first and only oral therapy and Janus kinase (JAK) inhibitor to be approved for this patient population.
In approving XELJANZ for UC, the European Medicines... More
Cowen NOT Recommending Chipotle Mexican (CMG) on Pullback
July 31, 2018 11:57 AM EDTCowen analyst Andrew Charles weighed in on Chipotle Mexican Grill (NYSE: CMG) following reports of foodborne illness surfacing at one Chipotle restaurant.
The analsyt said this is likely an isolated incident. However, they do not view the pullback as a buying opportunity given... More
